India’s largest pharma company Sun Pharmaceutical Industries Ltd. is selling central nervous system (CNS) divisions of erstwhile Ranbaxy to Strides Arcolab Ltd. for $25 million (Rs 165 crore), the company disclosed in a BSE filing on Saturday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
